《J Hosp Infect,2月6日,Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-10
  • Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents

    Günter Kampf, Daniel Todt, Stephanie Pfaender, Eike Steinmann

    DOI: https://doi.org/10.1016/j.jhin.2020.01.022

    Summary

    Currently, the emergence of a novel human coronavirus, temporary named 2019-nCoV, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for 2019-nCoV, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.

  • 原文来源:https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/fulltext
相关报告
  • 《MICROBES INFECT,2月2日,Is COVID-19 Receiving ADE From Other Coronaviruses?》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-22
    • Is COVID-19 Receiving ADE From Other Coronaviruses? Author links open overlay panelJason A.Tetro Show more https://doi.org/10.1016/j.micinf.2020.02.006 Abstract One of the most perplexing questions regarding the current COVID-19 coronavirus epidemic is the discrepancy between the severity of cases observed in the Hubei province of China and those occurring elsewhere in the world. One possible answer is antibody dependent enhancement (ADE) of SARS-CoV-2 due to prior exposure to other coronaviruses. ADE modulates the immune response and can elicit sustained inflammation, lymphopenia, and/or cytokine storm, one or all of which have been documented in severe cases and deaths. ADE also requires prior exposure to similar antigenic epitopes, presumably circulating in local viruses, making it a possible explanation for the observed geographic limitation of severe cases and deaths.
  • 《J Hosp Infect,3月6日,Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-08
    • Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV Jaffar A.Al-Tawfiq, Ziad A.MemishMD Show more https://doi.org/10.1016/j.jhin.2020.03.001 As of 29th February 2010 the World Health Organization had reported a total of 83 652 COVID-19 cases in 51 countries in addition of China [1]. The diagnosis of respiratory viruses such as Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and SARS-CoV relies on detection of the virus by real-time RT PCR (rRT-PCR) for in vitro qualitative detection. The current recommendations are likewise to use rRT-PCR for the detection of SARS-CoV-2 in respiratory samples. There are many knowledge gaps facing the global health community in dealing with the new emerging SARS-CoV-2. Among the most pertinent is early identification of cases to facilitate application of isolation policies.